AzTrials
AzTrials

Clinical TrialPREDI-DEPNCT03081065

Mediterranean Diet and Recurrence of Depression

A study testing Mediterranean Diet in people with Clinical Trial and Depression, run by University of Las Palmas de Gran Canaria.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

OBJECTIVES:To assess the effect of the intervention with Mediterranean Diet (MD) supplemented with extra virgin olive oil (EVOO) or tree nuts (TN) during 2 years (compared to a control group without intervention) on the risk of recurrence of unipolar depressive disorder in patients with partial or total remission for… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Clinical Trial, Depression, Mediterranean, Diet
What is being tested?
Mediterranean Diet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
750 participants
Where
No sites listed yet
Study dates
20 Mar 2017to 30 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adults
  • with a previous diagnosis of depression in the last 5 years and in a stage of total or partial remission

Who cannot join

  • presence of comorbid psychiatric disorders (anxiety, bipolar disorder, personality disorders, alcohol and drug abuse, mania, psychosis)
  • presence of severe medical condition with survival lower than one year)
  • history of food allergy with hypersensitivity to any of the components of olive oil or nuts
  • presence of disorders of chewing or swallowing
  • difficulties to change dietary habits
  • institutionalized patients and those participants who lack autonomy

Trial locations and contacts

No sites are listed yet.

Almudena Sanchez-Villegas, PhD contact

+34 928452794

almudena.sanchez@ulpgc.es

About this study

Official title: Nutritional Intervention With Mediterranean Diet in the Prevention of Recurrence of Depression

OBJECTIVES:To assess the effect of the intervention with Mediterranean Diet (MD) supplemented with extra virgin olive oil (EVOO) or tree nuts (TN) during 2 years (compared to a control group without intervention) on the risk of recurrence of unipolar depressive disorder in patients with partial or total remission for unipolar depressive disorder (1). Differences between groups in changes in residual symptoms (2), quality of life (QL) (3), biochemical parameters (4) and in the risk of medical/psychiatric co-morbidities (5) will be also analyzed. Finally, gut microbiota and its changes will be collected and compared between groups (6). METHODS: Multicenter clinical trial with 3 arms of intervention (MD+EVOO; MD+TN;control) during 2 years. Adults with previous episodes of unipolar depressive disorder in partial or total remission stage (determined through Montgomery-Asberg questionnaire and MINI interview) will be included. Participants with current depression, psychiatric co-morbid disorders or with problems to follow dietary recommendations will be excluded. A recurrence ratio of 35% in the MD groups and of 50% in the control group will be considered (Hazard Ratio: 0.7). We estimate a sample size of 720 participants (750 to count for losses) (90% power and 5% alpha error). Intervention will be performed through postal mail (recipes and information), email, phone y new technologies (Web page/mobile app) with periodic contacts with psychiatrics and dieticians and postal mail for free EVOO and nuts supply. Information from participants will be gathered with validated questionnaires of diet, physical activity, QL, or symptoms using postal mail, email, Web page or the phone. The analyses will be performed by intention to treat.

Read the detailed description

DESIGN This trial is a multicenter, parallel clinical trial with 3 intervention arms, two of them with Mediterranean Diet (MD) supplemented extra virgin olive oil (EVOO) or tree nuts (TN) and the last one is the control group without any kind of nutritional intervention.

SAMPLE Seven groups across Spain have agreed to participate in the trial and will recruit participants. With a 5% alpha error, 90% power and considering an incidence of recurrence of depression after 2 years of intervention of 35% in the MD groups and of 50% in the control group, we will need 240 participants in each group. Considering also possible losses, finally we have estimated a sample size of 750 participants, 108 participants in each of the recruitment centers.

The inclusion criteria were defined after an exhaustive review of the scientific literature and under consensus among all the psychiatric and clinical psychologists included in the study. We will include 1 participant with a unique episode of depression for each three participants with 2 or more episodes.

SELECTION OF PARTICIPANTS Clinical psychologists and psychiatrists will carry out the pre-selection of the participants after a detailed review of their clinical records. When a participant is pre-selected, the psychiatrists will perform a semi-structured interview (MINI interview) according to DSM-V criteria and a Montgomery-Asberg Depression Rating Scale to discard depression and other mental disorders diagnoses and to assess depression remission degree. This information will be completed with some questions included in the eligibility questionnaire such as medical conditions or problems related with the adherence to the MD. Moreover, participants will receive detailed written information of the study and the informed consent that they have to sign. The nurse will perform a venipuncture to obtain a blood sample according to the normal protocol. Moreover, in a subsample of the sample the participants will be instructed to collect a stool sample. Finally, all the data will be transferred to the dietitians of the study.

The dietitians of the study will be responsible for the periodic contact with the participants and to perform the nutritional intervention and follow-up. Contacts will be made through new technologies such as a web platform, a mobile app, telephone and email. Additionally, if a participant is not familiarized with these technologies, the dieticians will use postal mail to send all the information.

RANDOMIZATION AND INTERVENTION The study dietitians will perform the randomization of the participants to the corresponding intervention group following tables of random allocation according to the recruitment order balanced by age, group, and recruitment center. The randomization process will be performed from the coordination center. The psychiatrists who will perform mental evaluation of the participants will not participate in the process of randomization to avoid knowing to which group has been assigned each patient.

MD groups The protocol used in this trial is similar to that applied in the PREDIMED trial. In fact, the dietitians of this trial have participated in the PREDIMED trial and are collaborating also in the PREDIMED-PLUS.

The MD group will receive EVOO (A 1-liter free supply every 2 weeks) or TN (20 grams per day).

In the beginning of the trial the dietitian will provide a comprehensive number of reasons to adopt a MD to each participant, and will negotiate a change in his/her diet, working with the subject to determine what he or she considers an attainable goal. This compliance degree will be assessed every 3 months by the dietician through a telephone call to the participants. Every 3 months participants will also receive information about food items typical of the MD and adapted to the season of the year, a quantitative 1-week buying list of food items according to the season of the year, a weekly plan of meals (with detailed menus) adapted to the buying list and cooking recipes for cuisine practices according to the suggested menus.

Web page and mobile app will be updated each week with news related MD and its health effects.

Any doubt or suggestion made by our participants will be taken into account by our dietitians at any moment of the intervention period.

Control group Control group will not receive any kind of nutritional intervention although these participants will have an email and access to the project web page but with some limits for contents related with the intervention. To avoid losses during follow-up in the group, these participants will receive some incentives such as cinema tickets or discount vouchers in supermarkets

INFORMATION ASSESSMENT

  1. MINI interview To assess mental disorders diagnosis
  2. Montgomery-Asberg Depression Rating Scale questionnaire (Med Clin 2002;118:493-9) To assess depressive symptoms severity
  3. Eligibility questionnaire: to assess presence of severe diseases, food allergies and assessment of the willingness to make diet changes (Prochaska model)
  4. Baseline general and follow-up questionnaires: Socio-economic, anthropometric and life-style variables and diagnosis of diseases and use of psychotherapy and medication
  5. Conformity to the Mediterranean diet questionnaire (J Nutr 2011; 141:1140-5)
  6. Semi-quantitative food frequency questionnaire (Br J Nutr 2010;103:1808-16)
  7. Minnesota physical activity questionnaire (Am J Epidemiol 1994;139:1197-209)
  8. SF-36 quality of life questionnaire (Gac Sanit 2005;19 :135-50)

A clinical interview will be administered to discard a diagnosis of depression at baseline. This interview will be repeated every year. Coinciding with the medical visit blood extraction will be performed every year. Stool samples will be collected in a subsample both in the beginning and at the end of the trial.

Every four months psychiatrists will administer the Montgomery-Asberg questionnaire by telephone except in the beginning of the study or once a year in which the questionnaire will administer face to face in the consulting room. If there is any suspicion of depression reported by the psychiatrist after the telephone interview or reported by any patient relative the participants will be cited to attend the consulting room.

The adherence to the MD, nutrient and food intake, physical activity and quality of life will be assessed through validated questionnaires that were already used in the PREDIMED trial. The dietitians will collect information on diet, physical activity, quality of life and medical and life-style variables at baseline and yearly using new technologies, and the telephone.

Being tested
Mediterranean Diet
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mediterranean DietDietary supplement

    Nutritional advice to follow a Mediterranean diet and supplementation with extra virgin olive oil and nuts

Study groups in NCT03081065
Study groupRoleWhat they receive
Mediterranean Diet+ extra virgin olive oilExperimentalFree supply with extra virgin olive oil and nuts plus educational advice
Receives: Dietary Supplement: Mediterranean Diet
Mediterranean Diet+ tree nutsExperimentalFree supply with tree nuts plus educational advice
Receives: Dietary Supplement: Mediterranean Diet
ControlNo interventionUsual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time until recurrence of depression (defined as a clinical diagnosis of unipolar depressive disorder made by a Psychiatrist from the research team)

    New diagnoses of episodes of depression (recurrent depression as participants have a history of unipolar depressive disorder).

    Measured: From date of randomization until the date of first documented depressive episode diagnosis assessed up to 32 months

Secondary outcomes (6)
  1. Change in depressive symptoms using the Montgomery Asberg Depression Rating Scale

    Short (from baseline to the 1st-y) and long (from baseline to the 2nd-y) changes in depressiove symptoms (quantitative measure)

    Measured: Yearly (baseline, 1-year, 2-year of follow-up)

  2. Change in quality of life using the SF-36 quality of life questionnaire

    Short (from baseline to the 1st-y) and long (from baseline to the 2nd-y) changes in the eight domains (4 physical and 4 mental domains) of the SF-36 questionnaire

    Measured: Yearly (baseline, 1-year, 2-year of follow-up)

  3. Change in biochemical parameters (plasma levels of total cholesterol, HDL-cholesterol, LDL-cholesterol, glucose, protein C Reactive)

    Short (from baseline to the 1st-y) and long (from baseline to the 2nd-y) changes in biochemical parameters

    Measured: Yearly (baseline, 1-year, 2-year of follow-up)

  4. Change in microbiota in stool samples

    Gut microbial diversity and DNA analysis and their changes during the trial

    Measured: Change from baseline to the second year of follow-up

  5. Incidence of physical diseases (Clinically confirmed after an exhaustive review of clinical records of the participants)

    New diagnoses of medical diseases (mainly cancer, cardiovascular disease, metabolic syndrome or diabetes) reported by the participants in the follow-up questionnaires (later confirmed)

    Measured: From date of randomization until the date of first documented physical disease diagnosis assessed up to 32 months

  6. Incidence of other psychiatric disorders (clinical diagnosis made by a Psychiatrist from the research team)

    New diagnoses of psychiatric disorders made by a psychiatrist during the follow up period (bipolar disorder, schizophrenia, personality disorder, mania, eating disorders, drug abuse and anxiety disorder)

    Measured: From date of randomization until the date of first documented psychiatric disorder diagnosis assessed up to 32 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2017
  2. Study start20 Mar 2017 (estimated)
  3. Primary completion30 Nov 2019 (estimated)
  4. Study completion30 Nov 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
750 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03081065
Sponsor's protocol ID
ULPGC
Acronym
PREDI-DEP
Status last verified
Mar 2017
First submitted
6 Feb 2017
Last updated
15 Mar 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Cabrera-Suarez BM, Lahortiga-Ramos F, Sayon-Orea C, Hernandez-Fleta JL, Gonzalez-Pinto A, Molero P, Vega-Perez R, Sanchez-Villegas A; PREDI-DEP investigators. Effect of a dietary intervention based on the Mediterranean diet on the quality of life of patients recovered from depression: Analysis of the PREDIDEP randomized trial. Exp Gerontol. 2023 May;175:112149. doi: 10.1016/j.exger.2023.112149. Epub 2023 Mar 20.

    PubMed 36933773
  • Cabrera-Suarez B, Pla J, Gonzalez-Pinto A, Hernandez J, Chiclana-Actis C, Ortuno F, Florido-Rodriguez M, Sanchez-Villegas A, Investigators PD. 'Effectiveness of a remote nutritional intervention to increase the adherence to the Mediterranean diet among recovered depression patients'. Nutr Neurosci. 2023 Aug;26(8):696-705. doi: 10.1080/1028415X.2022.2081448. Epub 2022 Jul 11.

    PubMed 35816397
  • Sanchez-Villegas A, Cabrera-Suarez B, Molero P, Gonzalez-Pinto A, Chiclana-Actis C, Cabrera C, Lahortiga-Ramos F, Florido-Rodriguez M, Vega-Perez P, Vega-Perez R, Pla J, Calvino-Cabada MJ, Ortuno F, Navarro S, Almeida Y, Hernandez-Fleta JL. Preventing the recurrence of depression with a Mediterranean diet supplemented with extra-virgin olive oil. The PREDI-DEP trial: study protocol. BMC Psychiatry. 2019 Feb 11;19(1):63. doi: 10.1186/s12888-019-2036-4.

    PubMed 30744589

Questions about this trial

What is this clinical trial studying?

A study testing Mediterranean Diet in people with Clinical Trial and Depression, run by University of Las Palmas de Gran Canaria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Almudena Sanchez-Villegas, PhD (+34 928452794, almudena.sanchez@ulpgc.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time until recurrence of depression (defined as a clinical diagnosis of unipolar depressive disorder made by a Psychiatrist from the research team) (time frame: From date of randomization until the date of first documented depressive episode diagnosis assessed up to 32 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03081065, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in